Xi'an International Medical Investment Company Limited

SZSE:000516 Stock Report

Market Cap: CN¥13.3b

Xi'an International Medical Investment Past Earnings Performance

Past criteria checks 0/6

Xi'an International Medical Investment's earnings have been declining at an average annual rate of -8.8%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 30.6% per year.

Key information

-8.8%

Earnings growth rate

-4.4%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate30.6%
Return on equity-13.9%
Net Margin-7.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Oct 01
After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Jul 16
Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Jun 20
Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Mar 25
Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

Feb 28
Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

Revenue & Expenses Breakdown

How Xi'an International Medical Investment makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:000516 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,880-3586306
30 Jun 244,829-3206327
31 Mar 244,732-3996638
31 Dec 234,618-36866210
30 Sep 234,141-57266016
30 Jun 233,853-80366317
31 Mar 233,465-82365616
01 Jan 232,711-1,17764016
30 Sep 222,786-1,06464715
30 Jun 222,683-1,05866914
31 Mar 222,594-1,06866413
31 Dec 212,921-82266313
30 Sep 212,583-4163512
30 Jun 212,2733054511
31 Mar 211,9645248510
31 Dec 201,6074545810
30 Sep 201,391-8824609
30 Jun 201,188-7534719
31 Mar 201,046-62244810
31 Dec 19991-4043978
30 Sep 19896-682776
30 Jun 19872-192134
31 Mar 191,1082,1932282
31 Dec 182,0392,1842992
30 Sep 182,9732,2443960
30 Jun 183,6172,2804530
31 Mar 184,1301524500
31 Dec 174,0601954380
30 Sep 174,0241904050
30 Jun 173,9841914080
31 Mar 173,9442144060
31 Dec 163,9312024130
30 Sep 163,8722604030
30 Jun 163,8662174140
31 Mar 163,8661974100
31 Dec 153,9002413980
30 Sep 153,9273283780
30 Jun 153,9603693770
31 Mar 153,9293823600
31 Dec 143,8833503670
30 Sep 143,7862133750
30 Jun 143,6451683640
31 Mar 143,6041423670
31 Dec 133,5661223640

Quality Earnings: 000516 is currently unprofitable.

Growing Profit Margin: 000516 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 000516 is unprofitable, and losses have increased over the past 5 years at a rate of 8.8% per year.

Accelerating Growth: Unable to compare 000516's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 000516 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.7%).


Return on Equity

High ROE: 000516 has a negative Return on Equity (-13.88%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies